Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries S&P Biotech Bull 3X ETF Direxion (NY: LABU ) 146.96 +4.59 (+3.22%) Official Closing Price Updated: 8:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about S&P Biotech Bull 3X ETF Direxion Can These 5 Assets Skyrocket Your Portfolio? September 22, 2024 Are Verizon, Amazon, Cisco, Amgen, and the S&P Biotech Bull 3X Shares ETF poised to make your portfolio skyrocket? In this video, I take a closer look. Via Talk Markets Topics ETFs Stocks Exposures US Equities EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks August 30, 2024 Direxion's Ed Egilinsky says there are several sectors could be impacted in the current rotation trade environment. Via Benzinga Tech Powers S&P 500, Nasdaq, Leveraged ETFs Win June 06, 2024 Wall Street piled up strong gains in yesterday’s trading session, with the S&P 500 hitting the 25th record high this year and the Nasdaq Composite Index touching another record. Via Talk Markets Topics ETFs Stocks Exposures US Equities The 3 Best Leveraged ETFs for April 2024 April 02, 2024 If you want to speculate on baskets of securities, then these best leveraged ETFs for April could be what the doctor ordered. Via InvestorPlace Topics ETFs Sector Rotation January 08, 2022 In this video, I discuss sector rotation out of technology stocks and into consumer staple, energy, and bank stocks. Via Talk Markets 5 Best-Performing Leveraged ETFs Of February March 02, 2024 U.S. stocks rallied in February, with the S&P 500 and the Nasdaq Composite Index recording the best month in nearly a decade. Amid this environment, here are some of the best-performing leveraged... Via Talk Markets Topics ETFs Stocks Exposures US Equities Stocks To Watch This Week - Sunday, Feb. 11 February 11, 2024 This week, we take a look at small-cap and mid-cap stocks by using ETFs such as MDY and the leveraged ETF TNA. We also like the look of the LABU ETF. Via Talk Markets Topics ETFs Want Diversified Upside in Biotechnology? Check out LABU March 22, 2023 Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. Via MarketBeat Topics ETFs Stocks Exposures US Equities The Week Ahead Commentary - Saturday, Feb. 4 February 05, 2023 Robert Desmond looks at ETF and individual equities for the week just ended and gives his take on trading for the week to come. Via Talk Markets J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps January 17, 2023 Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing. Via Talk Markets 3 Leveraged ETF Stocks to Buy During This Extreme Uncertainty February 22, 2022 Here are 3 stocks to buy on dips from scary geopolitical risks from Russia. These leveraged ETFs move extremely fast so bring your Dramamine. Via InvestorPlace The Dean Martin, “You’re Nobody ‘Till Somebody Loves You” Stock Market (And Sentiment Results)… February 11, 2022 China Tech (Alibaba) and Biotech have been the two least-loved sectors in recent weeks, but we believe this is changing. Via Talk Markets 3 Biotech Stocks to Buy That Are Under Severe Pressure January 13, 2022 The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom. Via InvestorPlace 5 Best Leveraged ETFs of Last Week December 28, 2021 The S&P 500 hit a record close last week, courtesy of a Santa Clause rally. Wall Street was charged-up with the S&P 500 (up 1.22%), the Dow Jones (up 0.15%), the Nasdaq Composite (up 3.12%) and the... Via Talk Markets 5 Best-Performing Leveraged ETFs of August September 01, 2021 Here are some best-performing leveraged equity ETFs from different corners of the market that gained in double digits in August. Via Talk Markets The Week In Charts: Figure This Out And You’ll Own The World August 07, 2021 A discussion on trading hot IPOs and some of the issues that have arisen in recent times. Via Talk Markets The Week In Charts: Trading Stuff Part 3 - Trading (Or Not Trading!) OGRes, Russian Dolls, ETFs July 31, 2021 A look at lessons learned from active trading of IPOs, ETFs, Russian Dolls, and a discussion on what might be the secret to trading-which ironically, is the polar opposite to trading. Via Talk Markets The Week In Charts: Trading Stuff Part 2-IPOs, ETFs, And, The Secret To Trading July 23, 2021 A look at lessons learned from active trading including what might be the secret to trading-which ironically is the polar opposite to trading. Via Talk Markets These Were The Stocks David Green Discussed On His Show This Morning July 06, 2021 David Green made money day trading Bridgeline Digital Inc (NASDAQ: Via Benzinga The Week In Charts-Volatility: Rabbit Hole Or Holy Grail? June 11, 2021 A revisit using volatility to let us know when the elusive Via Talk Markets A Biotech ETF For Aggressive, Risk-Tolerant Investors June 08, 2021 The Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) seeks the daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Index for a single day. Via Talk Markets Topics Stocks Exposures US Equities A Biotech ETF For Aggressive, Risk-Tolerant Investors June 08, 2021 The biotechnology sector has been on fire thanks to news from Biogen Inc. (NASDAQ: BIIB). The FDA approved its controverisal drug that can treat Alzheimer’s Disease. Not... Via Benzinga Exposures Product Safety CrowdStrike Stock Earnings Trade June 06, 2021 In this video, we review the CrowdStrike stock earnings trade. We also review our top five stocks for the new trading week. Via Talk Markets This Biotech Stock Could See A Big Move If It Breaks Out Of The Pennant It's Forming May 05, 2021 Humanigen Inc. (NASDAQ: HGEN) shares made gains Wednesday following the publication of results from a Phase 3 randomized double-blind placebo-controlled study. The... Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
